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BACKGROUND: No data exist on the population prevalence of, or risk factors for, human papillomavirus (HPV) infection in
predominantly Muslim countries in Asia.
METHODS: Cervical specimens were obtained from 899 married women aged 15–59 years from the general population of Karachi,
Pakistan and from 91 locally diagnosed invasive cervical cancers (ICCs). HPV was detected using a GP5þ/6þ PCR-based assay.
RESULTS: The prevalence of HPV in the general population was 2.8%, with no evidence of higher HPV prevalence in young women.
The positivity of HPV was associated with women’s lifetime number of sexual partners, but particularly with the age difference
between spouses and other husbands’ characteristics, such as extramarital sexual relationships and regular absence from home.
The HPV16/18 accounted for 24 and 88% of HPV-positive women in the general population and ICC, respectively.
CONCLUSION: Cervical cancer prevention policies should take into account the low HPV prevalence and low acceptability of
gynaecological examination in this population.
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To date, there are no data on the population prevalence of, or risk
factors for, human papillomavirus (HPV) infection in predomi-
nantly Muslim countries in Asia, where sexual mores differ from
many other world populations (Wellings et al, 2006). These data
are essential to assess the potential relevance of HPV vaccination
and HPV test-based screening to invasive cervical cancer (ICC)
prevention in the region, as well as to identify any changes in risk
occurring in young generations. Thus, a study of women with and
without cervical cancer was carried out in Karachi, Pakistan,
according to the standardised protocol of the International Agency
for Research on Cancer (IARC) HPV Prevalence Surveys (Clifford
et al, 2005), which was approved by both the IARC and local
ethical review committees.
METHODS
A total of 3882 married women aged 15–59 years living in Orangi,
a densely populated suburb of Karachi, were visited at their homes
and invited to join the study, with the aim to enrol B100 women in
each 5-year age group. Participation rates were 24.1, 25.7, 25.1 and
23.6% among women aged 15–24, 25–34, 35–44 and 45–59 years,
respectively. All participants signed an informed consent form and
were administered a questionnaire. In all, 915 participants came to
the study clinic located in the Sindh Government Qatar Hospital,
where a sample of exfoliated cervical cells was collected and placed
into PreservCyt media (Hologic, Marlborough, MA, USA) for HPV
testing and liquid-based cytology.
In parallel, formalin-fixed tumour biopsies were retrieved from
women presenting with histologically confirmed ICC between 2004
and 2008 to the Ziauddin and Aga Khan University Hospitals,
Karachi. After exclusion of 40 biopsies that were b-globin negative
and/or without histological evidence of tumour, 91 ICCs remained
(79 squamous cell, 3 adeno, 4 small cell and 5 other or unspecified
carcinomas).
Liquid-based cytology and HPV testing were carried out at the
Vrije University, Amsterdam, the Netherlands. A general primer
GP5þ/6þ-mediated PCR was used for the detection of 44 genital
HPV types (Jacobs et al, 2000). Subsequent HPV typing was
carried out by reverse-line blot hybridisation of PCR products
(van den Brule et al, 2002). Odds ratios (ORs) for HPV positivity
were calculated by unconditional logistic regression adjusted
for age, with OR trends assessed by considering categories as
continuous variables.
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Among 899 women from the general population with valid
cytology and HPV results, HPV prevalence was 2.8% (Table 1).
Cervical abnormalities were diagnosed in 2.4% of women, of whom
27.3% were HPV-positive. They included 19 atypical squamous
cells of undetermined significance (4 HPV-positive), 1 low-grade
squamous intraepithelial lesion (HPV16/66-positive) and
2 high-grade squamous intraepithelial lesions (1 HPV-negative; 1
HPV16-positive, later revealed to be ICC). HPV16 was confirmed
as the most common type among women with both normal (0.5%)
(Clifford et al, 2005) and abnormal (9.1%) cytology. HPV16 was
also the predominant HPV type (75.8%) in ICC, followed by
HPV18 (6.6%) and 45 (4.4%) (Table 1).
Having X2 lifetime sexual partners was reported by 5.6% of
women, and was significantly associated with HPV positivity
(OR¼3.36; 95% confidence interval (CI): 1.08–10.41), as was
being a working woman (OR¼3.01; 95% CI: 1.26–7.21) (Table 2).
In addition, HPV infection was strongly associated with husbands’
characteristics, such as extramarital sexual relationships
(OR¼4.40; 95% CI: 1.83–10.56), absence from home 47 nights
per month (OR¼4.84; 95% CI: 1.30–17.95) and a X10 year age
difference between spouses (OR¼6.88; 95% CI: 1.48–31.94)
(Table 2). Husbands’ characteristics were correlated with each
other, but associations were unaffected by adjustment for women’s
lifetime number of sexual partners.
The positivity of HPV did not vary significantly by age (Table 2).
Neither were there any significant associations with education
level, marital status, number of full-term pregnancies, age at sexual
debut (Table 2), language/ethnic group (87.5% Urdu speakers),
birth outside Karachi (44.9%), use of condom (19.7%), hormonal
contraceptives (16.7%) and intrauterine device (7.2%), tubal
ligation (5.2%), history of spontaneous (35.2%) or induced
(11.5%) abortions, smoking (1.7%) or previous Pap smear
(1.1%) (data not shown).
DISCUSSION
This study disclosed a very low burden of HPV infection in the
general female population of Karachi, considerably lower than that
found using similar protocols in nearby India (17%) (Franceschi
et al, 2005), China (15–18%) (Dai et al, 2006; Li et al, 2006; Wu
et al, 2007) and Nepal (9%) (Sherpa et al, 2010), and 410-fold
lower than in sub-Saharan Africa (e.g., 51% in Guinea, also a
predominantly Muslim country) (Keita et al, 2009). There was no
evidence of higher prevalence in younger women, confirming the
flat age-specific curve seen in other low-resource countries in Asia
and Africa (Franceschi et al, 2006), although at much lower HPV
prevalence. An HPV prevalence of 27.3% in cervical abnormalities
is also low compared with high-resource settings (IARC, 2005),
highlighting problems in specificity of even gold-standard cytology
in settings of very low HPV prevalence.
The HPV16 accounted for three-quarters of ICC in Pakistan,
confirming the high prevalence of HPV16 observed in ICC from
the Indian subcontinent compared with other world regions
(Franceschi et al, 2003; Basu et al, 2009; Gheit et al, 2009). Indeed,
our data would suggest that the predominance of HPV16 over
other high-risk types might be even greater in settings of low HPV
exposure.
Major study strengths include a large population-based
sample, use of a standardised and well-validated HPV test allowing
comparisons with similar studies around the world (Clifford
et al, 2005) and with a concurrent series of ICC from the same
area. The main limitation, which was nevertheless an important
finding in itself, was the low participation rate, for which the
principal reasons were lack of husband’s permission and/or
lack of appreciation of screening in the absence of symptoms.
As HPV infection is asymptomatic, it is unlikely that participation
was highly correlated to HPV positivity. However, hesitancy to
undergo gynaecological examination would be a strong
obstacle to any future cervical cancer screening efforts in Pakistan
(Imam et al, 2008). Furthermore, vaginal examination was
acceptable only to married women, as in similar surveys in Asia
(Franceschi et al, 2005; Dai et al, 2006; Sherpa et al,
2010). Nevertheless, 98.2% of women reported an age at sexual
debut concurrent with, or just after, age at marriage, suggesting
that marriage may be a good proxy of sexual debut in this
population.
In conclusion, the low HPV prevalence in this study is consistent
with the low ICC risk estimate from Karachi (7.5/100000 cases
annually; rarer than the breast, mouth, ovary and oesophagus)
(Curado et al, 2007) and other predominantly Muslim countries in
Asia (Curado et al, 2007) and, reassuringly, there is no evidence
that HPV prevalence is higher in young generations of urban
women. However, 80% of the ICC that do develop in this
population (of which one was newly diagnosed by our study) are
attributable to HPV16/18. These findings should be taken into
account when considering the cost-effectiveness of ICC prevention
modalities in a population in which the burden of HPV and other
sexually transmitted infections (Zaheer et al, 2009) seems low,
but the burden of many other chronic infectious diseases
(e.g., tuberculosis (Hasan et al, 2009) and hepatitis C virus
(Ahmad, 2004)) is high.
Table 1 Prevalence of HPV types in 899 women from the general
population and 91 women with ICC in Karachi, Pakistan
General population
Normal
cytology
Abnormal
cytology All
(%)
ICC
All
(%)
HPV
type Sing. Mult.
Total
(%) Sing. Mult.
Total
(%)
N 877 22 899 91
HPV+ 16 3 19 (2.2) 3
a 3
b 6 (27.3) 25 (2.8) 83
c (92.2)
High-risk
16 3 1 4 (0.5) 1
a 1
b 2 (9.1) 6 (0.7) 69 (75.8)
18 — — — — — — — 6 (6.6)
33 — — — — — — — 1 (1.1)
35 2 — 2 (0.2) — — — 2 (0.2) —
45 — — — — 1 1 (4.5) 1 (0.1) 4 (4.4)
51 1 1 2 (0.2) — — — 2 (0.2) —
56 2 — 2 (0.2) — — — 2 (0.2) 2 (2.2)
59 1 — 1 (0.1) — — — 1 (0.1) 1 (1.1)
68 — — — — 1 1 (4.5) 1 (0.1) —
Any 9 2 11 (1.3) 1 3 4 (18.2) 15 (1.7) 81 (89.0)
Low-risk
6 2 — 2 (0.2) 1 — 1 (4.5) 3 (0.3) —
40 — 1 1 (0.1) — — — 1 (0.1) —
42 2 2 4 (0.5) — — — 4 (0.4) 1 (1.1)
d
43 — — — — 1 1 (4.5) 1 (0.1) —
54 1 — 1 (0.1) — — — 1 (0.1) —
66 — — — — 1
b 1 (4.5) 1 (0.1) 1 (1.1)
67 — 1 1 (0.1) — — — 1 (0.1) —
69 — — — — — — — 1 (1.1)
70 — 2 2 (0.2) — — — 2 (0.2) —
84 1 — 1 (0.1) — — — 1 (0.1) —
CP6108 1 — 1 (0.1) — 1 1 (4.5) 2 (0.2) —
Any 7 3 10 (1.1) 1 3 4 (18.2) 14 (1.6) 3 (3.3)
X — — — 1 — 1 (4.5) 1 (0.1) 1 (1.1)
Abbreviations: HPV¼human papillomavirus; ICC¼invasive cervical cancer;
mult.¼multiple; sing.¼single.
aIncluding one woman with high-grade squamous
intraepithelial lesion or ICC.
bIncluding one woman with low-grade squamous
intraepithelial lesion.
cIncluding three multiple infections (16/18, 16/18/66, 16/69),
which are each counted separately.
dOne ICC was positive for a low-risk type only.
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Table 2 ORs for HPV positivity and corresponding 95% CIs according to selected characteristics among 899 women in Karachi, Pakistan
HPV-positive
Characteristic N women
a N %O R
b 95% CI
Age (years)
o25 199 4 2.01 1 —
25–34 235 7 2.98 1.50 0.43–5.19
35–44 246 6 2.44 1.22 0.34–4.38
X45 219 8 3.65 1.85 0.55–6.24
w
2
1 for trend 0.71 P¼0.4
Education level
Secondary or higher 209 3 1.44 1 —
Primary or middle 319 6 1.88 1.35 0.33–5.49
Illiterate 371 16 4.31 3.22 0.88–11.84
w
2
1 for trend 4.31 P¼0.04
Occupation
Housewife 774 17 2.20 1 —
Employed 125 8 6.40 3.01 1.26–7.21
Marital status
Married, husband has one wife 784 20 2.55 1 —
Married, husband has more than one wife 44 2 4.55 1.69 0.38–7.51
Separated or divorced 26 2 7.69 3.36 0.74–15.36
Widow 45 1 2.22 0.70 0.09–5.61
Number of full-term pregnancies
0 110 3 2.73 1.24 0.31–4.98
1–3 302 7 2.32 1 —
X4 480 15 3.13 1.21 0.39–3.78
w
2
1 for trend 0 P¼1
Lifetime number of sexual partners
1 845 20 2.37 1 —
X2 50 4 8.00 3.36 1.08–10.41
Age at sexual debut (years)
p15 176 7 3.98 1 —
16–18 333 6 1.80 0.46 0.15–1.41
X19 389 12 3.08 0.83 0.30–2.29
w
2
1 for trend 0.01 P¼0.9
Age difference with husband
c
0–4 years 269 2 0.74 1 —
5–9 years 366 10 2.73 3.66 0.79–16.87
X10 years 193 10 5.18 6.88 1.48–31.94
w
2
1 for trend 7.25 P¼0.007
Husband’s extramarital sexual relationships
c
No 693 12 1.73 1 —
Yes 134 10 7.46 4.40 1.83–10.56
Husband away from home 47 nights per month
c
No 801 19 2.37 1 —
Yes 26 3 11.54 4.84 1.30–17.95
Abbreviations: CI¼confidence interval; HPV¼human papillomavirus; OR¼odds ratio.
aSome figures do not add up to the total because of few missing values.
bAdjusted
for age.
cRestricted to currently married women only (N¼828).
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